TalkMed Group Ltd. (SG:5G3) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
TalkMed Group Ltd. has announced its subsidiary BioCell Innovations Pte. Ltd.’s non-binding MOU with Thermo Fisher Scientific to improve the manufacturing of CAR-T immunotherapies in the Asia-Pacific. This collaboration aims to accelerate the development of cell therapies by leveraging BioCell’s vector design expertise and Thermo Fisher’s cell processing technologies. The company will keep its shareholders informed about significant future developments.
For further insights into SG:5G3 stock, check out TipRanks’ Stock Analysis page.
